English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Uterine fibroids or leiomyomas are common benign tumors often associated with menorrhagia, pressure symptoms and dysmenorrhea. selective progesterone receptor modulators (sPrMs) such as ulipristal acetate (UPA) have been proven a safe and effective treatment resulting in significant volume reduction of uterine fibroids and amenorrhea. safety concerns of long-term use of UPA have mainly focused on endometrial changes, which have been proven to be benign and self-resolving. case report: A 44-year-old woman presented with symptomatic subserosal fibroid of 7.5 cm in diameter and was prescribed UPA for three months. After a positive initial treatment response, a repeated three-month course of UPA was started. At the end of the second course the patient became symptomatic presenting with cyclic abdominal pain. Ultrasound imaging revealed a large multilocular cystic pelvic mass sized 10x11 cm suspicious of a malignant tumor and abdominal hysterectomy was performed.

journal of case reports and images in obstetrics and gynecology

Repeated intermittent use of ulipristal acetate associated with rapid growth and multilocular cystic hydropic degeneration of a uterine fibroid: A case report